Journals
Publish with us
Publishing partnerships
About us
Blog
Evidence-Based Complementary and Alternative Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Evidence-Based Complementary and Alternative Medicine
/
2022
/
Article
/
Tab 1
/
Research Article
Identification of Key Drug Targets and Molecular Mechanisms of Curcumae Rhizoma Acting on HBV-Related HCC: Weighted Correlation Network and Network Pharmacological Analyses
Table 1
Potential active compounds of Curcumae Rhizoma.
Mol. ID
Molecule name
MW
OB (%)
DL
MOL000296
Hederagenin
414.79
36.91
0.75
MOL000906
Wenjine
282.37
47.93
0.27
MOL000940
Bisdemethoxycurcumin
308.35
77.38
0.26